Published in J Neuropathol Exp Neurol on January 01, 2000
Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest (2003) 2.60
Expression of Nrf2 in neurodegenerative diseases. J Neuropathol Exp Neurol (2007) 1.95
Oxidative stress and diabetes: what can we learn about insulin resistance from antioxidant mutant mouse models? Free Radic Biol Med (2011) 1.35
Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated alpha-synuclein. J Neuroinflammation (2007) 1.30
Glutathione binding to the Bcl-2 homology-3 domain groove: a molecular basis for Bcl-2 antioxidant function at mitochondria. J Biol Chem (2007) 1.26
Nitrated alpha-synuclein and microglial neuroregulatory activities. J Neuroimmune Pharmacol (2008) 1.15
The effect of alpha-synuclein knockdown on MPP+ toxicity in models of human neurons. Eur J Neurosci (2008) 1.13
Frataxin, iron-sulfur clusters, heme, ROS, and aging. Antioxid Redox Signal (2006) 1.12
The antioxidative effect of electro-acupuncture in a mouse model of Parkinson's disease. PLoS One (2011) 1.02
Toxin models of mitochondrial dysfunction in Parkinson's disease. Antioxid Redox Signal (2011) 0.97
Antioxidant gene therapy against neuronal cell death. Pharmacol Ther (2013) 0.92
Compartmentalized oxidative stress in dopaminergic cell death induced by pesticides and complex I inhibitors: distinct roles of superoxide anion and superoxide dismutases. Free Radic Biol Med (2013) 0.91
Lack of glutathione peroxidase-1 exacerbates Abeta-mediated neurotoxicity in cortical neurons. J Neural Transm (Vienna) (2005) 0.90
Transcriptional activation in yeast in response to copper deficiency involves copper-zinc superoxide dismutase. J Biol Chem (2008) 0.89
Role of copper,zinc-superoxide dismutase in catalyzing nitrotyrosine formation in murine liver. Free Radic Biol Med (2008) 0.88
Mitochondria: redox metabolism and dysfunction. Biochem Res Int (2012) 0.87
Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease. Neurobiol Dis (2013) 0.84
Targeting the progression of Parkinson's disease. Curr Neuropharmacol (2009) 0.82
Behavioral and neurotransmitter abnormalities in mice deficient for Parkin, DJ-1 and superoxide dismutase. PLoS One (2013) 0.81
Adaptation to chronic MG132 reduces oxidative toxicity by a CuZnSOD-dependent mechanism. J Neurochem (2008) 0.81
Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health Implications. Physiol Rev (2016) 0.81
Synergy between glutathione peroxidase-1 and astrocytic growth factors suppresses free radical generation and protects dopaminergic neurons against 6-hydroxydopamine. Rejuvenation Res (2011) 0.80
The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease. Int J Mol Sci (2011) 0.80
Protective mechanisms of mitochondria and heart function in diabetes. Antioxid Redox Signal (2015) 0.78
Nitric Oxide Synthase Inhibitor Improves De Novo and Long-Term l-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats. Front Syst Neurosci (2011) 0.78
Downregulation of thioredoxin reductase 1 expression in the substantia nigra pars compacta of Parkinson's disease mice. Neural Regen Res (2013) 0.77
Epigenetic modifications and NF-κB pathway activity in Cu,Zn-SOD-deficient mice. Mol Cell Biochem (2014) 0.75
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell (1982) 9.27
CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study. Neurology (2007) 4.24
The use of pKc30 and its derivatives for controlled expression of genes. Methods Enzymol (1983) 3.90
Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology (2007) 3.67
Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal (1997) 2.77
Maximizing gene expression from plasmid vectors containing the lambda PL promoter: strategies for overproducing transcription termination factor rho. Proc Natl Acad Sci U S A (1985) 2.70
Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol Heart Circ Physiol (2001) 2.38
Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol (1978) 2.37
Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am J Pathol (1999) 2.31
Red cells from glutathione peroxidase-1-deficient mice have nearly normal defenses against exogenous peroxides. Blood (2000) 2.19
Neural transplantation in Huntington disease: long-term grafts in two patients. Neurology (2007) 2.15
Bacteriophage lambda protein cII binds promoters on the opposite face of the DNA helix from RNA polymerase. Nature (1983) 2.13
Quinone chemistry and toxicity. Toxicol Appl Pharmacol (1992) 2.11
The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest (1996) 2.07
Isolation of type 5 adenovirus mutants with a cold-sensitive host range phenotype: genetic evidence of an adenovirus transformation maintenance function. Virology (1982) 1.99
Testing process errors and their harms and consequences reported from family medicine practices: a study of the American Academy of Family Physicians National Research Network. Qual Saf Health Care (2008) 1.98
Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol (1978) 1.79
Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J Mol Cell Cardiol (1998) 1.72
Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem (1998) 1.71
Regulation of sodium-calcium exchange and mitochondrial energetics by Bcl-2 in the heart of transgenic mice. J Mol Cell Cardiol (2001) 1.65
Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy. J Neuropathol Exp Neurol (2000) 1.63
Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology (2005) 1.56
Mitochondrial superoxide production in kainate-induced hippocampal damage. Neuroscience (2000) 1.53
Left atrial ball thrombus in nonrheumatic atrial fibrillation diagnosed by transesophageal echocardiography. Am Heart J (1992) 1.46
Strategies for the prevention of environmental neurotoxic illness. Environ Res (1993) 1.44
A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology. Brain (2007) 1.40
Targeted mutation of the gene for cellular glutathione peroxidase (Gpx1) increases noise-induced hearing loss in mice. J Assoc Res Otolaryngol (2000) 1.39
The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin. J Neurochem (1999) 1.32
Extracellular superoxide dismutase, nitric oxide, and central nervous system O2 toxicity. Proc Natl Acad Sci U S A (1992) 1.31
Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases. Thyroid (1999) 1.30
The Duke University program for integrating ethics and human values into medical education. Acad Med (1989) 1.29
L&H variants of Reed-Sternberg cells express sialylated Leu M1 antigen. Am J Pathol (1986) 1.29
Glutathione peroxidase-1 deficiency leads to increased nuclear light scattering, membrane damage, and cataract formation in gene-knockout mice. Invest Ophthalmol Vis Sci (2001) 1.29
Uncommon morphologic features in subacute sclerosing panencephalitis (SSPE). Report of two cases with virus recovery from one autopsy brain specimen. Am J Pathol (1970) 1.27
Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. Am J Pathol (2001) 1.26
Human Gi protein alpha-subunit: deduction of amino acid structure from a cloned cDNA. FEBS Lett (1987) 1.25
Targeted disruption of the mouse Sod I gene makes the hearts vulnerable to ischemic reperfusion injury. Circ Res (2000) 1.24
Hereditary motor and sensory neuropathy, X-linked: a half century follow-up. Neurology (1987) 1.23
Glutathione peroxidase-deficient mice are more susceptible to neutrophil-mediated hepatic parenchymal cell injury during endotoxemia: importance of an intracellular oxidant stress. Hepatology (1999) 1.23
Removal of Cr(VI) from aqueous solutions using agricultural waste 'maize bran'. J Hazard Mater (2007) 1.23
In vivo aminoacylation of human and Xenopus suppressor tRNAs constructed by site-specific mutagenesis. Proc Natl Acad Sci U S A (1987) 1.22
H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: A study with transgenic mice heterozygous for targeted disruption of the Heme oxygenase-1 gene. Circulation (2001) 1.20
Cellular glutathione peroxidase knockout mice express normal levels of selenium-dependent plasma and phospholipid hydroperoxide glutathione peroxidases in various tissues. J Nutr (1997) 1.20
Characterization of a third, cII-dependent, coordinately activated promoter on phage lambda involved in lysogenic development. J Biol Chem (1985) 1.20
cDNA and deduced amino acid sequence of rat copper-zinc-containing superoxide dismutase. Nucleic Acids Res (1987) 1.19
Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury. J Cereb Blood Flow Metab (2000) 1.18
Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury. J Mol Cell Cardiol (1996) 1.17
Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: relevance to Parkinson's disease. Neuroscience (2004) 1.17
Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. Am J Pathol (1997) 1.16
Cellular glutathione peroxidase is the mediator of body selenium to protect against paraquat lethality in transgenic mice. J Nutr (1998) 1.16
Areca nut extract and arecoline induced the cell cycle arrest but not apoptosis of cultured oral KB epithelial cells: association of glutathione, reactive oxygen species and mitochondrial membrane potential. Carcinogenesis (2001) 1.14
Clinical and pathological characteristics of secondary thyroid cancer. Thyroid (1998) 1.14
Changes in expression of antioxidant enzymes affect cell-mediated LDL oxidation and oxidized LDL-induced apoptosis in mouse aortic cells. Arterioscler Thromb Vasc Biol (2001) 1.14
4-Hydroxy-2(E)-nonenal inhibits CNS mitochondrial respiration at multiple sites. J Neurochem (1999) 1.12
The Gpx1 gene encodes mitochondrial glutathione peroxidase in the mouse liver. Arch Biochem Biophys (1997) 1.12
The toxicity of melanin precursors. J Invest Dermatol (1978) 1.12
Survival impact of lymph node metastasis in TNM stage III carcinoma of the colon and rectum. J Am Coll Surg (1995) 1.10
The role of 2,4,5-trihydroxyphenylalanine in melanin biosynthesis. J Biol Chem (1977) 1.10
Nasopharyngeal Castleman's disease. J Formos Med Assoc (1996) 1.09
Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid. Biochemistry (2000) 1.09
Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons. Virology (2000) 1.09
Experimental focal segmental glomerulosclerosis in mice. Nephron (1998) 1.08
Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques. Neurology (2010) 1.07
Primary cardiac chondrosarcoma. Am J Emerg Med (1996) 1.07
Pulmonary-specific expression of SP-D corrects pulmonary lipid accumulation in SP-D gene-targeted mice. Am J Physiol Lung Cell Mol Physiol (2000) 1.06
Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. Neurotoxicology (1984) 1.05
Spinal extradural cavernous hemangioma. Surg Neurol (1990) 1.03
Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype. J Neuropathol Exp Neurol (1998) 1.02
Selenium-dependent glutathione peroxidase-GI is a major glutathione peroxidase activity in the mucosal epithelium of rodent intestine. Biochim Biophys Acta (1998) 1.02
Neurotoxicity of endogenous cysteinylcatechols. Exp Neurol (1997) 1.02
Diaphragmatic defect as a cause of massive hydrothorax in cirrhosis of liver. J Clin Gastroenterol (1988) 1.01
Intracranial meningeal melanocytoma: CT and MRI. Neuroradiology (1997) 1.01
Glutathione peroxidase protects mice from viral-induced myocarditis. FASEB J (1998) 1.01
Infiltrative polyneuropathy due to acute monoblastic leukemia in hematologic remission. Neurology (1987) 1.01
Cervical ecchordosis physaliphora: CT and MR features. Br J Radiol (1998) 1.01
Glutathione peroxidase knockout mice are susceptible to myocardial ischemia reperfusion injury. Circulation (1997) 1.00
Crosslinking of apolipoprotein E by products of lipid peroxidation. J Neuropathol Exp Neurol (1996) 0.99
Sural nerve biopsy in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve (1989) 0.99
Cardiac myocytes exposed to anoxia-reoxygenation promote neutrophil transendothelial migration. Am J Physiol Heart Circ Physiol (2001) 0.98
Acrolein inhibits respiration in isolated brain mitochondria. Biochim Biophys Acta (2001) 0.98
Evidence for functional relatedness of products encoded by the transforming sequences of human adenovirus types 5 and 12. Virology (1981) 0.97
E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. Am J Pathol (1996) 0.96
On the origin and significance of neuromelanin. Arch Pathol Lab Med (1979) 0.96
Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assay. Clin Chim Acta (2001) 0.95
Biochemical and ultrastructural study of Leu M1 antigen in Reed-Sternberg cells: comparison with granulocytes and interdigitating reticulum cells. J Natl Cancer Inst (1986) 0.95
4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease. J Neuropathol Exp Neurol (1997) 0.95
Hepatotoxicity and hepatocarcinogenicity in rats fed squid with or without exogenous nitrite. Food Chem Toxicol (1992) 0.95
Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases. Endocr Relat Cancer (1999) 0.94
Massive pulmonary embolus and anabolic steroid abuse. JAMA (1992) 0.94
Immunoglobulin A nephropathy and ankylosing spondylitis. Report of two patients in Taiwan and review of the literature. Nephron (1988) 0.94
Environmental neurotoxic illness: research for prevention. Environ Health Perspect (1994) 0.93
Mutations that alter the DNA binding site for the bacteriophage lambda cII protein and affect the translation efficiency of the cII gene. J Mol Biol (1984) 0.93
Selective dendritic degeneration of medium spiny neurons in dementia with Lewy bodies. Neurology (2006) 0.93
Lack of cerebral bmaa in human cerebral cortex. Neurology (2009) 0.93